Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT05327062
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- XSpline S.p.A.
- Registry
-
NCT05327062
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Austria, Hungary, Italy, Netherlands, Spain, Switzerland
- Registry status
- Unknown status
Technical summary
Registry record NCT05327062. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-03-06 (actual); primary completion 2025-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
- Acronym
- CRT-DRIVE
- Condition
- Cardiac Resynchronization Therapy
- Condition
- Chronic Heart Failure
- Condition
- Left Bundle-Branch Block
- Intervention (Device)
- CRT implantation guided by XSpline, a non-invasive electrical and venous anatomy assessment
- Lead sponsor
- XSpline S.p.A.
Record details
- Record id
cardio:ct-nct05327062- Content hash
3f211b50d0a0b578e3eeb7cf46b60e28455ec3920115fe618335a01a343c5376